Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Living Lactobacillus Vaginal Capsules for Persistent High-risk HPV Infection (Real-world Multicenter Study)
ChiCTR2600130581Phase 4Not yet recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Aug 2026
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of lactobacillus vaginal capsules in human papillomavirus infection (2 arms), sponsored by Obstetrics and Gynecology Hospital of Fudan University. Primary endpoint: HPV clearance rate at Month 6. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
lactobacillus vaginal capsules
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on ChiCTR2600130581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130581.